Veritone Releases Preliminary, Unaudited Q4 2025 Results and Reveals Strategic Partnership with Oracle
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Should l Buy VERI?
Source: moomoo
Preliminary Results: Veritone has released preliminary, unaudited results for Q4 2025, indicating significant developments in their financial performance.
Strategic Deal Announcement: The company has announced a strategic deal with Oracle, which is expected to enhance their operational capabilities and market reach.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VERI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VERI
Wall Street analysts forecast VERI stock price to rise
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 2.610
Low
6.00
Averages
8.33
High
10.00
Current: 2.610
Low
6.00
Averages
8.33
High
10.00
About VERI
Veritone, Inc. builds human-centered enterprise artificial intelligence (AI) solutions. Its AI operating system, aiWARE, uses machine learning algorithms, or AI models, together with a suite of applications, to reveal valuable insights from vast amounts of structured and unstructured data. Highly modular and customizable, aiWARE enables expansive scale with the flexibility to deploy in the cloud, at the edge or in hybrid environments. Its aiWARE platform offers capabilities that are designed to mimic human cognitive functions such as perception, prediction and problem solving, enabling users to transform unstructured data into structured data, and analyze and optimize data to drive business processes and insights. Its aiWARE platform encompasses industry applications, automate studio and developer APIs, intelligent data lake, applications and cognitive analytics, and generative AI. It serves customers in the media, entertainment, public sector and talent acquisition industries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Veritone Reports Q4 Revenue of $11 Million, Falling Short of IBES Estimate of $34.3 Million
Veritone Q4 Revenue: Veritone reported a revenue of USD 11 million for the fourth quarter.
Ibes Estimate: In contrast, Ibes estimated Veritone's revenue to be significantly higher at USD 34.3 million.
See More
Veritone Releases Preliminary, Unaudited Q4 2025 Results and Reveals Strategic Partnership with Oracle
Preliminary Results: Veritone has released preliminary, unaudited results for Q4 2025, indicating significant developments in their financial performance.
Strategic Deal Announcement: The company has announced a strategic deal with Oracle, which is expected to enhance their operational capabilities and market reach.
See More
Stock Futures Rise as Trump Delays Military Action Against Iran
- Unity Software Growth: Unity Software shares surged 15% after raising its Q1 revenue outlook to $505M-$508M, exceeding previous guidance of $480M-$490M, driven by strong performance in its Unity Vector offering, with Create revenue expected around $115M and Grow at $353M, while adjusted EBITDA is projected at $130M-$135M, indicating robust growth potential.
- Argan's Strong Performance: Argan shares rose 9% following a 13% year-over-year revenue increase in Q4, with both gross and EBITDA margins expanding by 450 basis points, and the company highlighted robust demand with $2.5B in new contracts added during the year, ending with a project backlog exceeding $2.9B, showcasing strong growth and profitability momentum.
- Zenas BioPharma Financing Plans: Zenas BioPharma shares fell 12% after announcing a dual capital raise, including $200M in 2.50% convertible senior notes and a 5M-share equity offering priced at $20 per share, with expected net proceeds of approximately $287.5M, indicating urgency in financing strategies as the notes mature in 2032.
- Veritone's Weak Preliminary Results: Veritone shares declined 8% after reporting preliminary Q4 revenue expectations of $18.1M-$30.0M, significantly below the $34.3M consensus, with preliminary GAAP net loss projected at $25.1M-$37.0M, reflecting financial pressures faced by the company.
See More
Veritone Reports Transformative Q4 2025 Earnings Insights
- Strategic Transaction Success: In Q4 2025, Veritone signed a complex multiparty nonmonetary transaction valued at $12.9 million, securing preferred access to over 50 million hours of monetizable data sets, with projected VDR revenue exceeding $100 million over three years, significantly enhancing the company's revenue potential and market competitiveness.
- Partnership with Oracle: The company established a multiyear strategic partnership with Oracle to deploy Veritone's aiWARE platform and data services on Oracle Cloud Infrastructure, marking a pivotal milestone that further solidifies Veritone's leadership in managing unstructured data.
- Financial Health Improvement: In Q4, Veritone fully retired its senior secured term debt and repurchased approximately 50% of its convertible notes, reducing annual debt carrying costs to $800,000 and closing the quarter with $27.7 million in cash and cash equivalents, indicating a significant improvement in the company's financial health.
- Optimistic Future Outlook: The CFO projected fiscal 2026 revenue between $130 million and $145 million, representing a 47% year-over-year increase, with public sector revenue expected to grow by 60% to 70%, indicating the company's intent to capture a larger share of the AI data economy.
See More
Veritone (VERI) Q4 2025 Earnings Call Transcript
See More
Veritone Announces Preliminary Q4 2025 Financial Results and Strategic Partnerships
- Financial Guidance: Veritone expects revenue for fiscal 2026 to range between $130 million and $145 million, representing a 47% year-over-year increase from the low end of 2025, indicating strong demand and growth potential in the AI market.
- Strategic Partnership: The multi-year strategic partnership with Oracle will accelerate the deployment of Veritone's aiWARE platform on Oracle Cloud Infrastructure, expected to significantly enhance the company's cloud computing efficiency and market competitiveness.
- Data Resource Expansion: Through transactions with new clients, Veritone has gained access to over 50 million hours of monetizable data sets, projected to generate over $100 million in VDR revenue over the next three years, further solidifying its leadership in the data market.
- Public Sector Growth: Veritone's public sector business is expected to grow between 60% to 70% year-over-year in 2026, driven by the expansion of existing federal contracts and new international deals, showcasing the company's strong execution in the government market.
See More
Veritone Reports Q4 Revenue of $11 Million, Falling Short of IBES Estimate of $34.3 Million
Veritone Q4 Revenue: Veritone reported a revenue of USD 11 million for the fourth quarter.
Ibes Estimate: In contrast, Ibes estimated Veritone's revenue to be significantly higher at USD 34.3 million.
See More
Veritone Releases Preliminary, Unaudited Q4 2025 Results and Reveals Strategic Partnership with Oracle
Preliminary Results: Veritone has released preliminary, unaudited results for Q4 2025, indicating significant developments in their financial performance.
Strategic Deal Announcement: The company has announced a strategic deal with Oracle, which is expected to enhance their operational capabilities and market reach.
See More
Stock Futures Rise as Trump Delays Military Action Against Iran
- Unity Software Growth: Unity Software shares surged 15% after raising its Q1 revenue outlook to $505M-$508M, exceeding previous guidance of $480M-$490M, driven by strong performance in its Unity Vector offering, with Create revenue expected around $115M and Grow at $353M, while adjusted EBITDA is projected at $130M-$135M, indicating robust growth potential.
- Argan's Strong Performance: Argan shares rose 9% following a 13% year-over-year revenue increase in Q4, with both gross and EBITDA margins expanding by 450 basis points, and the company highlighted robust demand with $2.5B in new contracts added during the year, ending with a project backlog exceeding $2.9B, showcasing strong growth and profitability momentum.
- Zenas BioPharma Financing Plans: Zenas BioPharma shares fell 12% after announcing a dual capital raise, including $200M in 2.50% convertible senior notes and a 5M-share equity offering priced at $20 per share, with expected net proceeds of approximately $287.5M, indicating urgency in financing strategies as the notes mature in 2032.
- Veritone's Weak Preliminary Results: Veritone shares declined 8% after reporting preliminary Q4 revenue expectations of $18.1M-$30.0M, significantly below the $34.3M consensus, with preliminary GAAP net loss projected at $25.1M-$37.0M, reflecting financial pressures faced by the company.
See More
Veritone Reports Transformative Q4 2025 Earnings Insights
- Strategic Transaction Success: In Q4 2025, Veritone signed a complex multiparty nonmonetary transaction valued at $12.9 million, securing preferred access to over 50 million hours of monetizable data sets, with projected VDR revenue exceeding $100 million over three years, significantly enhancing the company's revenue potential and market competitiveness.
- Partnership with Oracle: The company established a multiyear strategic partnership with Oracle to deploy Veritone's aiWARE platform and data services on Oracle Cloud Infrastructure, marking a pivotal milestone that further solidifies Veritone's leadership in managing unstructured data.
- Financial Health Improvement: In Q4, Veritone fully retired its senior secured term debt and repurchased approximately 50% of its convertible notes, reducing annual debt carrying costs to $800,000 and closing the quarter with $27.7 million in cash and cash equivalents, indicating a significant improvement in the company's financial health.
- Optimistic Future Outlook: The CFO projected fiscal 2026 revenue between $130 million and $145 million, representing a 47% year-over-year increase, with public sector revenue expected to grow by 60% to 70%, indicating the company's intent to capture a larger share of the AI data economy.
See More
Veritone (VERI) Q4 2025 Earnings Call Transcript
See More
Veritone Announces Preliminary Q4 2025 Financial Results and Strategic Partnerships
- Financial Guidance: Veritone expects revenue for fiscal 2026 to range between $130 million and $145 million, representing a 47% year-over-year increase from the low end of 2025, indicating strong demand and growth potential in the AI market.
- Strategic Partnership: The multi-year strategic partnership with Oracle will accelerate the deployment of Veritone's aiWARE platform on Oracle Cloud Infrastructure, expected to significantly enhance the company's cloud computing efficiency and market competitiveness.
- Data Resource Expansion: Through transactions with new clients, Veritone has gained access to over 50 million hours of monetizable data sets, projected to generate over $100 million in VDR revenue over the next three years, further solidifying its leadership in the data market.
- Public Sector Growth: Veritone's public sector business is expected to grow between 60% to 70% year-over-year in 2026, driven by the expansion of existing federal contracts and new international deals, showcasing the company's strong execution in the government market.
See More
